PACB position history
The shares of Pacific Biosciences Calif (PACB) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 22,723,075 shares, $581M, 1.4% of portfolio
- 2021 Q4: 26,383,103 shares, $540M, 1.6% of portfolio, Add +16.1%
- 2022 Q1: 27,259,521 shares, $248M, 1.0% of portfolio, Add +3.3%
- 2022 Q2: 28,045,530 shares, $158M, 0.93% of portfolio, Add +2.9%
- 2022 Q3: 28,692,494 shares, $167M, 1.2% of portfolio, Add +2.3%
- 2022 Q4: 25,691,681 shares, $210M, 1.8% of portfolio, Reduce −10.5%
- 2023 Q1: 27,753,679 shares, $321M, 2.2% of portfolio, Add +8.0%
- 2023 Q2: 26,634,620 shares, $354M, 2.3% of portfolio, Reduce −4.0%
- 2023 Q3: 29,822,440 shares, $249M, 1.9% of portfolio, Add +12.0%
- 2023 Q4: 34,504,273 shares, $338M, 2.0% of portfolio, Add +15.7%
- 2024 Q1: 33,290,137 shares, $125M, 0.86% of portfolio, Reduce −3.5%
- 2024 Q2: 33,212,454 shares, $46M, 0.40% of portfolio, Reduce −0.2%
- 2024 Q3: 33,406,401 shares, $57M, 0.52% of portfolio, Add +0.6%
- 2024 Q4: 36,044,362 shares, $66M, 0.55% of portfolio, Add +7.9%
- 2025 Q1: 36,478,441 shares, $43M, 0.43% of portfolio, Add +1.2%
- 2025 Q2: 36,298,163 shares, $45M, 0.33% of portfolio, Reduce −0.5%
- 2025 Q3: 30,924,103 shares, $40M, 0.24% of portfolio, Reduce −14.8%
- 2025 Q4: 37,264,228 shares, $70M, 0.46% of portfolio, Add +20.5%
- 2026 Q1: 36,273,288 shares, $48M, 0.37% of portfolio, Reduce −2.7%
- 2026 Q2: 29,781,416 shares, $50M, 0.32% of portfolio, Reduce −17.9%
- 2026 Q3: 29,749,893 shares, $71M, 0.41% of portfolio, Reduce −0.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|